About us

EVIANA was listed on the Canadian Securities Exchange (CSE), and trades under the symbol EHC.

Our story

Wisdom of nature

EVIANA was established to deliver the highest quality, organic, sustainable CBD (cannabinoid) from natural hemp strains of cannabis sativa (industrial hemp). CBD will be used in customized consumer health-care products, pharmaceuticals, nutraceuticals, and cosmeceuticals in addition to topical creams and other health and wellness products.

EVIANA is listed on the Canadian Securities Exchange (CSE), and trades under the symbol EHC.

Why Eviana?

Agricultural land in Serbia covers approx. 5.1 million hectares (ha), roughly 66% of total land, of which about 3.6 million ha are considered arable lands. The climate is classified as being temperate continental. Average annual precipitation ranges from 600mm to 800mm in the plains and between 800mm and 1,200mm in the mountains. Land and climate conditions are favorable to agricultural production.

Canada has the most developed and extensive network of businesses whose activity is focused on the production and/or processing of industrial hemp for the food industry. Therefore, EVIANA, as a Canadian company, with its operation center in Serbia intends to reprise Serbia’s role as a leader in Europe as an important center for cultivating and/or processing of industrial hemp for production of pharma grade and food grade CBD.

  • The Strong agricultural industry with Europe’s most fertile growing land
  • Serbian License to grow hemp on 100 hectares of agricultural land
  • Company operates a wholy integrated business model where the executes all phases of production
  • Team of highly specialized scientist with ability extract high-quality CBD with the use of Canadian engineered extraction machinery used by leading corporations in various industries of extraction
  • Significant demand for high-level CBD
  • Ease of access to European Market
  • Connection to North American through parent company
  • Owned and leased facilities necessary for production in Serbia

Why is production based in Serbia?

Serbia is a non-coastal country situated at the crossroads of Central and Southeast Europe located in the heart of the Balkan Peninsulas. The country is EU membership candidate since 2012, and member of UN and CEFTA. Ranking 48 out of 190 countries in The World Bank Doing Business Report 2019, Serbia is also acceding to the WTO.

  • optimal weather, soil, etc. allows for growth of Hemp that has higher than average CBD
  • Stable economy
  • Central location, ease of access to many other European countries – potential consumers of CBD
  • Business friendly environment
  • Lower cost of production, experienced workers
  • EU membership candidate
  • Assistance from Canadian Embassy who are favourable to our project and the economic benefits to be shared by Canada and Serbia

Agricultural land in Serbia covers approx. 5.1 million hectares (ha), roughly 66% of total land, of which about 3.6 million ha are considered arable lands. The climate is classified as being temperate continental. Average annual precipitation ranges from 600mm to 800mm in the plains and between 800mm and 1,200mm in the mountains. Land and climate conditions are favorable to agricultural production.

Low pollution levels and predominantly fertile organic land with naturally available sources of water coupled with established irrigation systems make Serbia an ideal destination to cultivate industrial hemp. The agricultural benefits of Serbian land were recognized long ago, so it is not surprising that Serbia is country with a long tradition of cultivating autochthonous species of industrial hemp. Historically, Serbia once had a Mercantile Cannabis Exchange Centre (in the city of Odzaci) and was a forefront of European cannabis production with 2/3 of entire hemp production in Europe. Today, the highest growth rates of hemp are in Europe (France).

Recent analyses show that Serbian autochthonous strains have higher percentage of CBD compared to other hemp strains.

Canada has the most developed and extensive network of businesses whose activity is focused on the production and/or processing of industrial hemp for the food industry. Therefore, EVIANA, as a Canadian company, with its operation center in Serbia intends to reprise Serbia’s role as a leader in Europe as an important center for cultivating and/or processing of industrial hemp for production of pharma grade and food grade CBD.

Meet our team

Dr. Avram Adizes
CEO, Director
Dr. Adizes has over 35 years of experience in the fields of research and development with international knowledge in creating and implementing top technology solutions. Dr. Adizes previously worked as a Professional Engineer in the 1980s and was a pioneer in the development of computer science. Dr. Adizes’ has substantial experience in the computer and information technologies marketplace and has the ability to implement new technologies in a wide variety of settings. Dr. Adizes established growth leading projects in fields of public health systems, medical digital image technology for diagnostic purposes, directed the development of security infrastructure according to international standards, allowing governments and businesses to communicate electronically with the general public and internally. Dr. Adizes holds P.Eng. in electrical engineering from the University of Pristina and Ph.D. in Computer Science from the joint program at Stanford University.
Sydney Au
CFO Director
Mr. Au has been active as the Founder, CEO and President of Evitrade Health Systems Corporation, a public digital healthcare technology company, since April 2012 (CSE: EVA) and is also the Founder, CEO and President of AK PlasticBagsOnline Inc., a private plastics extrusion manufacturing company, since April 2004. Mr. Au has experience as a director and officer in public companies in a wide range of industries since 2006. He has been active in the day to day operations of both private and public companies in various sectors and has assisted in developing value for shareholders. He has been involved in restructuring public companies and in various corporate transactions. Mr. Au holds a Bachelor of Arts (Commerce and Economics), a Bachelor of Science (Physical Geography) from the University of Toronto.
Prof. Dr. Ljiljana Vujotic
CMO Director
Dr. Vujotic has more than 30 years of experience in clinicial medicine as a specialist in the field of neurosurgery, as well as in the field of plastic and reconstructive surgery. Her last position was head of the Pediatric Neurosurgery Department, Clinical Center of Serbia, Neurosurgery Division in Belgrade, Serbia. She serves as a President of the NT Committee for Quality Improvement of Health Care in Serbia since 2004. Dr. Vujotic was also director of post-graduate studies and a full time professor of surgery at the School of medicine University of Belgrade. Dr. Vujotic holds MD, MSc and a Ph.D. from the University of Belgrade. Her most recent research is in the field of antioxidative stress enzymes and heavy metals in human tissues, with the goal to compare findings in healthy people with patients suffering from brain tumors (having found and published first results).
Paolo de Luca
Director, Member of the Board, Chief Financial Officer of Organigram Holdings
With more than 20 years of diversified financial business experience, Mr. De Luca has held senior financial, investor relations, and accounting leadership roles at companies including West Face Capital, one of Canada’s leading alternative asset management firms; Meridian LNG; Potash Ridge; C.A. Bancorp; and TD Securities. With this diverse industry and international background, he has extensive experience with both traditional and non-traditional financing and debt offerings. Mr. De Luca is a graduate of York University’s Schulich School of Business.
Copyright © Eviana Health Corporation, Inc.